Bristol-Myers Squibb and Tsinghua University of Beijing, China, have entered a multi-year strategic partnership under which BMS will fund research efforts at Tsinghua’s School of Life Sciences to identify and validate targets in oncology and immunoscience. The collaboration will also focus on structural biology research that could serve as the basis for future drug discovery projects.   “This is Bristol-Myers Squibb’s first discovery collaboration in China and is an example of the company’s deep...